Literature DB >> 11297626

Fractures after long-term alendronate therapy.

S M Ott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11297626     DOI： 10.1210/jcem.86.4.7436-1

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

1.  Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy.

Authors:  Kazuhiro Imai; Seizo Yamamoto; Yorito Anamizu; Toshiyuki Horiuchi
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

2.  Do not use bisphosphonates without scientific evidence, neither in treatment nor prophylactic, in the treatment of stress fractures.

Authors:  Ingrid Ekenman
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-05       Impact factor: 4.342

3.  Atypical femoral fractures, bisphosphonates, and mechanical stress.

Authors:  Per Aspenberg; Jörg Schilcher
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

Review 4.  Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report.

Authors:  Yusuf Farouk Suleman; Shabnum Meer; Russel Lurie
Journal:  Head Neck Pathol       Date:  2007-12-08

5.  Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment.

Authors:  Dawn L Hershman; Donald J McMahon; Katherine D Crew; Theresa Shao; Serge Cremers; Lois Brafman; Danielle Awad; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-12-18       Impact factor: 5.958

6.  Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid.

Authors:  Greg Wernecke; Surena Namdari; Surena Namduri; Edward F DiCarlo; Robert Schneider; Joseph Lane
Journal:  HSS J       Date:  2008-07-16

Review 7.  Use of bisphosphonates for the treatment of stress fractures in athletes.

Authors:  Yosuke Shima; Lars Engebretsen; Junji Iwasa; Katsuhiko Kitaoka; Katsuro Tomita
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-12-02       Impact factor: 4.342

8.  L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.

Authors:  Hussam A S Murad
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

9.  Temporal progression of skeletal cystic angiomatosis.

Authors:  Giridhar M Shivaram; Reetesh K Pai; Kevin B Ireland; Kathryn J Stevens
Journal:  Skeletal Radiol       Date:  2007-10-03       Impact factor: 2.199

10.  Effect of inappropriate and continuous therapy with alendronate for ten years on skeletal integrity - observations in two elderly patients.

Authors:  J R Tucci
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.